SIGAL ELLIOT

CIK 00012022943 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001202294

Recent Transactions

50 trades

Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−14,214→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−25,786→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−17,203→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−6,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−4,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−4,000→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2019-05-30−1,500→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-05-30+1,500→ 14,214 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2018-05-31−1,500→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2018-05-31+1,500→ 12,714 total
Award
Spark Therapeutics, Inc.
Restricted Stock Units
2018-05-30+1,500→ 1,500 total
Award
Spark Therapeutics, Inc.
Stock Option (right to buy)
2018-05-30+4,000→ 4,000 total
Sale
Spark Therapeutics, Inc.
Common Stock
2017-11-28$72.43/sh−29→ 11,214 total
Purchase
Spark Therapeutics, Inc.
Common Stock
2017-10-12$90.75/sh+29→ 11,243 total
Disposition to Issuer
Mead Johnson Nutrition Co
Common Stock
2017-06-15$90.00/sh−5,180→ 0 total
Disposition to Issuer
Mead Johnson Nutrition Co
Common Stock
2017-06-15$90.00/sh−2,590→ 0 total
Disposition to Issuer
Mead Johnson Nutrition Co
Common Stock
2017-06-15$90.00/sh−13,721→ 0 total
Disposition to Issuer
Mead Johnson Nutrition Co
Common Stock
2017-06-15$90.00/sh−5,180→ 0 total
Disposition to Issuer
Mead Johnson Nutrition Co
Restricted Stock Units
2017-06-15$90.00/sh−1,709→ 0 total
Award
Spark Therapeutics, Inc.
Restricted Stock Units
2017-05-31+1,500→ 1,500 total
Award
Spark Therapeutics, Inc.
Stock Option (right to buy)
2017-05-31+4,000→ 4,000 total
Exercise/Conversion
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2017-03-01−2,373→ 0 total
Exercise/Conversion
Mead Johnson Nutrition Co
Common Stock
2017-03-01+2,373→ 13,721 total
Award
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2017-02-28+1,709→ 1,709 total
Award
Spark Therapeutics, Inc.
Stock Option (right to buy)
2016-06-01+6,000→ 6,000 total
Exercise/Conversion
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2016-02-29+2,373→ 2,373 total
Exercise/Conversion
Mead Johnson Nutrition Co
Common Stock
2016-02-26+1,678→ 11,348 total
Exercise/Conversion
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2016-02-26−1,678→ 0 total
Exercise/Conversion
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2015-02-28−2,146→ 0 total
Exercise/Conversion
Mead Johnson Nutrition Co
Common Stock
2015-02-28+2,146→ 9,670 total
Award
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2015-02-26+1,678→ 1,678 total
Award
Spark Therapeutics, Inc.
Series B Preferred Stock
2015-02-04+503→ 31,559 total
Conversion
Spark Therapeutics, Inc.
Series B Preferred Stock
2015-02-04−31,559→ 0 total
Purchase
Spark Therapeutics, Inc.
Common Stock
2015-02-04$23.00/sh+5,000→ 11,214 total
Conversion
Spark Therapeutics, Inc.
Common Stock
2015-02-04+31,559→ 31,559 total
Award
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2014-02-28+2,146→ 2,146 total
Exercise/Conversion
Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
2014-02-27−1,876→ 0 total
Exercise/Conversion
Mead Johnson Nutrition Co
Common Stock
2014-02-27+1,876→ 7,524 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-06-03$27.01/sh+98,875→ 231,868 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Executive Option (right to buy)
2013-06-03−98,875→ 25,000 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-06-03$48.18/sh−83,647→ 148,221 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Executive Option (right to buy)
2013-05-30−50,000→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Executive Option (right to buy)
2013-05-30−120,625→ 123,875 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-05-30$24.74/sh+50,000→ 276,514 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-05-30$27.01/sh+120,625→ 226,514 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-05-30$47.23/sh−143,521→ 132,993 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-04-30$39.65/sh−459→ 9,091 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-04-30$24.74/sh+202,405→ 355,898 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2013-04-30$25.45/sh+103,500→ 459,398 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Executive Option (right to buy)
2013-04-30−202,405→ 50,000 total

Companies

Recent Filings

Address

345 PARK AVENUE

NEW YORK, NY, 10154

View on SEC.gov